-
AstraZeneca-backed studies reveal constant risk of CV events and deathFindings from three real-world evidence clinical studies supported by AstraZeneca have indicated the need for better secondary prevention of long-term ischemic risk in people who have survived a heart2018/9/7
-
DuPont Nutrition & Health to Showcase YO-MIX® M11 at the Food Ingredients Asia 2018DuPont will also Share Findings from Recent Consumer Study,Which Demonstrates the Rising Demand for Nutritional Snacks in Southeast Asian Markets JAKARTA, Indonesia, September 5, 2018 –DuPont Nutriti2018/9/7
-
MannKind and United Therapeutics to advance dry powder treprostinilUS-based biopharmaceutical company MannKind has entered an exclusive licensing and collaboration agreement with United Therapeutics over a dry powder formulation of treprostinil. Treprostinil is a va2018/9/6
-
Sanofi agrees on monetary settlement for bribery chargesSanofi has agreed on a civil settlement with the US Securities and Exchange Commission (SEC) to resolve charges related to allegations of its subsidiaries paying bribes to win contracts. The French p2018/9/6
-
Sanofi’s Cablivi receives EC approval to treat rare blood disorderThe European Commission (EC) has granted marketing authorisation for Sanofi’s Cablivi (caplacizumab) indicated to treat adults with acquired thrombotic thrombocytopenic purpura (aTTP) episodes. Cabli2018/9/5
-
Former GSK researcher admits plot to steal trade secretsA former GlaxoSmithKline (GSK) researcher, Yu Xue, has pleaded guilty to a plot to steal the pharmaceutical company’s trade secrets for biopharmaceutical products in development to treat cancer and ot2018/9/5
-
Vertex and Genomics partner to use human genetics for precision medicinesUS-based Vertex Pharmaceuticals has signed a multi-year collaboration with British genome analysis company Genomics to leverage human genetics and data science for the discovery of precision medicin2018/9/4
-
Roquette appoints Rohit Markan as Managing Director for IndiaRoquette appoints Rohit Markan as Managing Director for India This appointment reaffirms Roquette’s leadership in India and supports the company’s growth ambitions in the country Mumbai (India), 3 Se2018/9/4
-
Chasing top HIV players, Merck scores FDA approval for 2 new drugsAfter marquee HIV drug approvals last year for Gilead and GlaxoSmithKline, Merck will follow into thecrowded marketwith two new meds. The drugmaker scored FDAapprovals for a new non-nucleoside rever2018/9/3
-
Kale yeah! Bayer caps Monsanto acquisition with living veggie billboards in St. LouisBayer’s newest billboards are literally sprouting up around St. Louis. Two boards went up last week with depictions of the iconic Gateway Arch planted in greenery—kale, collard greens and chard, speci2018/9/3